ICICI Prudential Healthcare Fund
- NAV as on 24 Sep 2026
- ₹43.37-0.64%1 day
- Return since launch
- 19.8%
- 52-week range
- ₹36.38 — ₹44.28
- AUM
- ₹6,996 Cr
ICICI Prudential Healthcare Fund is a Sectoral-Pharma equity fund from ICICI Prudential Mutual Fund with ₹6,996 Cr under management, launched in 2018. Over three years it has returned 14.4% a year, against 21.1% for its category. The expense ratio is 2.07% and the SEBI riskometer reading is Very High.
Performance
ICICI Prudential Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +8.7% against +17.6% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 14.4% | −4.6 pts | 19.0% | 26.9% |
| 2Y | 10.1% | −6.9 pts | 17.0% | 15.4% |
| 3Y | 14.4% | −6.8 pts | 21.1% | 16.1% |
| 5Y | 19.6% | +5.2 pts | 14.4% | 18.3% |
| 7Y | 20.3% | +1.0 pts | 19.4% | 18.3% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | -0.3% | −1.3 pts | 0.9% | 0.9% |
| 3M | 1.7% | −5.7 pts | 7.4% | 7.1% |
| 6M | 15.4% | −6.3 pts | 21.7% | 20.5% |
| 1Y | 8.7% | −10.2 pts | 19.0% | 17.6% |
| 2Y | 5.6% | −2.8 pts | 8.3% | 6.9% |
| 3Y | 22.3% | +1.1 pts | 21.1% | 20.6% |
| 5Y | 15.5% | +1.2 pts | 14.4% | 13.4% |
| 7Y | 24.2% | +1.6 pts | 22.6% | 21.3% |
Since launch (25 Jun 2018): 19.8%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -0.8% | +1.2 pts | -2.0% |
| 2024 | 47.7% | +6.8 pts | 40.9% |
| 2023 | 41.3% | +5.1 pts | 36.2% |
| 2022 | -8.5% | −0.2 pts | -8.3% |
| 2021 | 18.2% | −3.5 pts | 21.7% |
| 2020 | 71.4% | +2.6 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.07%
Expense ratio as on 22 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.54%
- Brokerage
- 0.07%
- Transaction charges
- 0.01%
- Statutory levies
- 0.45%
- Exit load
- Exit load of 1% if redeemed within 15 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | 0.21 | 0.88 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.96 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.01 | 1.06 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.45 | 1.68 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 16.12 | 15.56 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
ICICI Prudential Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity95.0%
- Other5.0%
Market cap split
- Large24.1%
- Mid32.5%
- Small43.4%
- P/E
- 41.60
- P/B
- 4.20
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 12.31% | ₹861 Cr | +12.09% | +11.21% | +11.71% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 8.26% | ₹578 Cr | +7.70% | +6.52% | +9.47% |
| Cipla Ltd. | Healthcare | 5.76% | ₹403 Cr | +7.45% | +9.40% | +7.39% |
| Mankind Pharma Ltd. | Healthcare | 5.21% | ₹365 Cr | +7.03% | +7.64% | +3.50% |
| Others | Others | 4.99% | ₹349 Cr | +0.02% | +0.02% | +0.41% |
| Alkem Laboratories Ltd. | Healthcare | 4.87% | ₹341 Cr | +4.08% | +3.47% | +4.00% |
| Divi's Laboratories Ltd. | Healthcare | 4.83% | ₹338 Cr | +6.06% | +5.95% | +9.23% |
| Biocon Ltd. | Healthcare | 4.68% | ₹327 Cr | +4.71% | +6.20% | +3.21% |
| Medplus Health Services Ltd. | Healthcare | 4.15% | ₹290 Cr | +3.86% | +2.54% | +1.28% |
| Cohance Lifesciences Ltd. | Healthcare | 4.08% | ₹286 Cr | +4.37% | +2.77% | — |
| Syngene International Ltd. | Healthcare | 3.29% | ₹230 Cr | +2.99% | +3.16% | +2.18% |
| company:19686 | Healthcare | 2.79% | ₹195 Cr | — | — | — |
| Max Healthcare Institute Ltd. | Healthcare | 2.59% | ₹181 Cr | +3.36% | — | — |
| Alembic Pharmaceuticals Ltd. | Healthcare | 2.48% | ₹173 Cr | +1.76% | +1.60% | +1.63% |
| Abbott India Ltd. | Healthcare | 2.38% | ₹166 Cr | +2.14% | — | — |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.99% | ₹139 Cr | +2.01% | +1.77% | — |
| Astrazeneca Pharma India Ltd. | Healthcare | 1.99% | ₹139 Cr | +0.78% | +0.76% | +0.76% |
| Lupin Ltd. | Healthcare | 1.96% | ₹137 Cr | +3.06% | +3.99% | +5.44% |
| Blue Jet Healthcare Ltd. | Healthcare | 1.93% | ₹135 Cr | +1.40% | +1.22% | — |
| company:19129 | Healthcare | 1.92% | ₹134 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 1.86% | ₹130 Cr | +1.98% | +1.34% | +1.51% |
| Metropolis Healthcare Ltd. | Healthcare | 1.74% | ₹122 Cr | +1.54% | +1.21% | +1.57% |
| Rainbow Children's Medicare Ltd. | Healthcare | 1.36% | ₹95.32 Cr | +1.44% | — | — |
| Thyrocare Technologies Ltd. | Healthcare | 1.30% | ₹90.72 Cr | +2.40% | +1.75% | +1.53% |
| Entero Healthcare Solutions Ltd. | Healthcare | 1.23% | ₹86.24 Cr | +1.74% | +1.46% | — |
| Fine Organic Industries Ltd. | Chemicals | 1.22% | ₹85.42 Cr | +1.19% | +1.17% | +1.14% |
| Alivus Life Sciences Ltd | Healthcare | 1.21% | ₹84.68 Cr | +1.77% | +2.11% | — |
| Medi Assist Healthcare Services Ltd. | Services | 1.13% | ₹79.26 Cr | +1.38% | +1.31% | +1.78% |
| Aarti Drugs Ltd. | Healthcare | 1.10% | ₹76.79 Cr | +1.10% | +0.98% | +1.18% |
| Hikal Ltd. | Healthcare | 1.05% | ₹73.34 Cr | +1.21% | +1.15% | +0.29% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.97% | ₹68.12 Cr | +1.02% | +0.88% | +0.89% |
| Manipal Health Enterprises Ltd. | Healthcare | 0.92% | ₹64.57 Cr | — | — | — |
| Laxmi Dental Ltd. | Healthcare | 0.67% | ₹46.84 Cr | +0.80% | +0.63% | — |
| FDC Ltd. | Healthcare | 0.62% | ₹43.22 Cr | +0.77% | +0.63% | +0.89% |
| Indoco Remedies Ltd. | Healthcare | 0.58% | ₹40.44 Cr | +0.47% | — | — |
| Windlas Biotech Ltd. | Healthcare | 0.57% | ₹40.17 Cr | +0.96% | +0.95% | +1.39% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| company:19686 | 0.00% | 2.79% | +2.79% |
| company:19129 | 0.00% | 1.92% | +1.92% |
| Divi's Laboratories Ltd. | 6.03% | 4.83% | -1.20% |
| Aurobindo Pharma Ltd. | 0.81% | 0.00% | -0.81% |
| Cipla Ltd. | 6.56% | 5.76% | -0.80% |
| Thyrocare Technologies Ltd. | 1.95% | 1.30% | -0.65% |
| Entero Healthcare Solutions Ltd. | 1.72% | 1.23% | -0.49% |
| Jupiter Life Line Hospitals Ltd. | 0.47% | 0.00% | -0.47% |
| Blue Jet Healthcare Ltd. | 2.39% | 1.93% | -0.46% |
| Sun Pharmaceutical Industries Ltd. | 12.69% | 12.31% | -0.39% |
| Medplus Health Services Ltd. | 3.80% | 4.15% | +0.35% |
| Biocon Ltd. | 4.97% | 4.68% | -0.29% |
| Lupin Ltd. | 2.23% | 1.96% | -0.26% |
| Mankind Pharma Ltd. | 5.47% | 5.21% | -0.26% |
| Abbott India Ltd. | 2.63% | 2.38% | -0.25% |
| Metropolis Healthcare Ltd. | 1.49% | 1.74% | +0.25% |
| Alkem Laboratories Ltd. | 5.11% | 4.87% | -0.24% |
| Max Healthcare Institute Ltd. | 2.81% | 2.59% | -0.22% |
| Manipal Health Enterprises Ltd. | 0.73% | 0.92% | +0.19% |
| Dr. Reddy's Laboratories Ltd. | 8.45% | 8.26% | -0.19% |
| Windlas Biotech Ltd. | 0.75% | 0.57% | -0.18% |
| Cohance Lifesciences Ltd. | 3.92% | 4.08% | +0.17% |
| Rainbow Children's Medicare Ltd. | 1.51% | 1.36% | -0.15% |
| Sanofi Consumer Healthcare India Ltd. | 1.12% | 0.97% | -0.14% |
| Hikal Ltd. | 1.18% | 1.05% | -0.14% |
| Medi Assist Healthcare Services Ltd. | 1.27% | 1.13% | -0.13% |
| Astrazeneca Pharma India Ltd. | 1.86% | 1.99% | +0.13% |
| FDC Ltd. | 0.74% | 0.62% | -0.12% |
| Alivus Life Sciences Ltd | 1.33% | 1.21% | -0.12% |
| Pfizer Ltd. | 1.97% | 1.86% | -0.11% |
| Akums Drugs And Pharmaceuticals Ltd. | 1.89% | 1.99% | +0.10% |
| Laxmi Dental Ltd. | 0.75% | 0.67% | -0.08% |
| Aarti Drugs Ltd. | 1.16% | 1.10% | -0.06% |
| Alembic Pharmaceuticals Ltd. | 2.43% | 2.48% | +0.05% |
| Fine Organic Industries Ltd. | 1.18% | 1.22% | +0.04% |
| Indoco Remedies Ltd. | 0.54% | 0.58% | +0.04% |
| Syngene International Ltd. | 3.26% | 3.29% | +0.03% |
| Others | 0.01% | 0.01% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,725 Cr | 2.22% | 31.0% | 18.9% | 20.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.3% | 20.2% | 22.4% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 31.0% | 18.9% | 20.0% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.9% | 19.5% | 21.3% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.6% | 17.0% | 18.0% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund managers
- Dharmesh KakkadMr. kakkad is B.com., CA & CFA.He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months15.41% absolute | ₹60,000 | ₹69,246 | 15.41% | |
| 1 year8.72% annualised | ₹1,20,000 | ₹1,25,822 | 4.85% | |
| 3 years22.26% annualised | ₹3,60,000 | ₹5,15,067 | 43.07% | |
| 5 years15.54% annualised | ₹6,00,000 | ₹9,10,572 | 51.76% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.